elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47158291-5052B02B-F4F9-426E-89FC-1167649AE684
Q47158291-5052B02B-F4F9-426E-89FC-1167649AE684
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47158291-5052B02B-F4F9-426E-89FC-1167649AE684
Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy.
P2860
Q47158291-5052B02B-F4F9-426E-89FC-1167649AE684
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47158291-5052B02B-F4F9-426E-89FC-1167649AE684
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ae91753694504efc96ce59670278ce6496442094
P2860
177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer.